Abstract deadline ISHAM congress extended +++ meeting of NSMM +++ course histopathology +++ Malassezia Working Group +++ pediatric dermatology +++ your ISHAM password

Guidelines, Recommendations and Essential Reviews

 

Clinical Practice Guidelines for the Management of Blastomycosis
(Stanley et al., CID 46: 1801-1812, 2008).

Clinical spectrum of Scedosporium
(Guarro et al., Med. Mycol. 44: 295-327, 2006).

Definitions of invasive fungal disease
(De Pauw et al., CID 46: 1813-1821, 2008).

NEW Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
(Segal et al., CID 47: 674-683, 2008).

NEW Diagnosis of invasive fungal infections in hematology and oncology
(Ruhnke et al., Ann Hematol (2003) 82 (Suppl 2):S141–S148)


(Pagani et al., JAC 50: 231-240, 2002)

NEW EUCAST_Technical Notes on Voriconazole testing_CMI 2008
(Clin Microbiol Infect 2008; 14: 985–987)

Management of blastomycosis
(Chapman et al., CID 46: 1801-1812, 2008).

Nomenclature of fungal disease
(Odds et al., J. Med. Vet. Mycol. 30: 1-10, 1992).

Primary cerebral infections
(Horré & de Hoog, Stud. Mycol. 43: 194-205, 1999).

NEW Practice Guidelines for the Treatment of Fungal Infections
(Sobel et al., CID 30: 652, 2000)

Treatment of aspergillosis
(Walsh et al., CID 46: 327-360, 2008).

Treatment of invasive fungal infections in adults
(Flückiger et al., Swiss Med. Weekly 136: 447-463, 2006).